Kellimq

Hello From Down Under, My hospital has implemented the two blood group policy for giving group specific red cells. I have had a question from our head anaesthetist about evidence that this practice is safer? Does anyone have any links to evidence or where it is written in any other guidelines around the world? Thanks! Kelli Quantock - Mater Hospital Brisbane, Australia

Hi Everyone, I run a major hospital blood bank in Australia. Have any of you have experience with the demand for blood/blood products eg Albumin during the CoVid19 pandemic? Did you experience an increase in requests for group and hold serum from these patients? Are they using any particular type of product more than others or at all? Just trying to develop plans and stock levels. Good luck to everyone out there dealing with this and stay safe!. Kelli

Hi Everyone, We did an IUT on a baby yesterday whose Mum has an anti-D quant of 847IU. Baby's pre-transfusion sample we tested on the Biovue card and the result was neg with the anti-A and anti-B but 4+ with the A,B. The D and the control well and DAT are also 4+. Any idea why the a,b is reacting with these cells? Thanks Kelli

Hi Everyone, We did an IUT on a baby yesterday whose Mum has an anti-D quant of 847IU. Baby's pre-transfusion sample we tested on the Biovue card and the result was neg with the anti-A and anti-B but 4+ with the A,B. The D and the control well and DAT are also 4+. Any idea why the a,b is reacting with these cells? Thanks Kelli

Hi, We recently also had a B (A) phenotype detected by the Ortho reagents. Our reactions were similar to yours. We are fortunate to have a R&D Rh gentoyping facility at our Reference Lab here in Brisbane, Australia who confirmed the B (A) phenotype. I confirmed with Ortho they are using the clone which detects this. We transfuse Group B where possible.

Hello All, I'm wanting some feedback regarding a project I have in mind. I have just had my first article accepted in Transfusion regarding a Mum with RhD*DNB causing haemolytic disease of the Newborn. During the research for this article, I couldn't find anywhere or anyone who was collating data on the efficacy of prophylactic anti-D injections on Mum's to be with D variants/partial-D's or the amount of anti-D IU required to be effective to prevent isoimmunisation. I work in the largest maternity hospital in Australia, about 10,000 births a year and I have been personally gathering some data on amount given, whether there was isoimmunisation during the pregnancy and whether the antibody screen was positive post-injection i.e. was there enough 'left-over' to hemolyse a FMH. I am looking a hosting a website where the international community could upload their cases so that we could build a database. What are your opinions? Would this be a useful project? Is someone else doing it? Thanks! Kelli Q

Thanks all. Don't worry, I am certainly here to learn from this process, and am happy to receive all constructive criticism. Will let you know if and when the article gets accepted! and p.s.you're right Pony, finding the time to write for a 24hr shift worker is extremely challenging!

Hello All, I am writing my first journal article for submission to the Transfusion Journal. As I have no experience in writing articles and submitting I have heard there are Editorial companies who can review your articles and help with the editing process. Does anyone know of any, and can recommend (or otherwise!) their work? Many Thanks Kelli

Hi GoodChild, in my previous life I was Process Control Manager for the Australian Red Cross Blood Service...I hear you

what QC do you do daily on your saline?

GD-CLN-900100.pdf Hi, We are a multidis non-trauma hospital, with a large (10,000 births/year) maternity hospital. We have found the use of Cryo in the first MTP pack to be advantageous in getting obstetric bleeds under control more quickly.

The patient has had a mitral valve repair and then CABG (now post-op day 5). Day 53 in ICU. The hb now appears to be stabilising. They are still monitoring her, but are hopeful they have found the cause of the hemolysis.

Thank you so much Malcolm. The intensivist was also querying mechinical destruction by the heart, so now that they know the anti-Ytb is unlikely to be the cause of the low grade hemolysis, they are going to do some cardiac investigations. Excellent references and once again Malcolm is the veritable font of information.

Hello, I have a case of an anti-Yt b been identified by our Reference Lab and I'm struggling to find out its clinical significance given its rarity. Does anyone know if it has been implicated in transfusion reactions? The intensivist says the patient is clinically showing signs of hemolysis, (Raised LDH and lowered haptoglobin). Many thanks! Kelli